S-Allyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka Long-Evans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism

Journal of Clinical Biochemistry and Nutrition

Volumn 53, Issue 2, 2013, Pages 94-101

  Takemura, Shigekazu ^a   Minamiyama, Yukiko ^a,b   Kodai, Shintaro ^b   Shinkawa, Hiroji ^b   Tsukioka, Takuma ^b   Okada, Shigeru ^c   Azuma, Hideki ^d   Kubo, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d Osaka Prefecture University   (Japan)

Author keywords

Diabetes mellitus type 2; OLETF; PPAR; S allyl cysteine; SREBP lc

Indexed keywords

CYSTEINE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE KINASE 4; S ALLYL CYSTEINE; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; LIPOGENESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RNA ISOLATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84885136780     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-1     Document Type: Article

References (28)

1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
2. Tamura Y, Tanaka Y, Sato F, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2005; 90: 3191-3196. (Pubitemid 41014274)
3. Torisu Y, Ikeda K, Kobayashi M, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Hepatol Res 2007; 37: 517-523. (Pubitemid 46864247)
4. Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic? Hepatol Res 2012; 42: 1-14.
5. Awad S, Constantin-Teodosiu D, Constantin D, et al. Cellular mechanisms underlying the protective effects of preoperative feeding: A randomized study investigating muscle and liver glycogen content, mitochondrial function, gene and protein expression. Ann Surg 2010; 252: 247-253.
6. Minamiyama Y, Takemura S, Bito Y, et al. Supplementation of a-tocopherol improves cardiovascular risk factors via the insulin signalling pathway and reduction of mitochondrial reactive oxygen species in type II diabetic rats. Free Radic Res 2008; 42: 261-271. (Pubitemid 351419912)
7. Minamiyama Y, Takemura S, Kodai S, et al. Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 2010; 298: El 140-E1149.
8. Rattan SI. Is gene therapy for aging possible? Indian J Exp Biol 1998; 36: 233-236.
9. Maldonado PD, Barrera D, Rivera I, et al. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003; 35: 317-324. (Pubitemid 37288932)
10. Numagami Y, Ohnishi ST. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr 2001; 131: U00S-U05S.
11. Saravanan G, Ponmurugan P. Beneficial effect of S-allylcysteine (SAC) on blood glucose and pancreatic antioxidant system in streptozotocin diabetic rats. Plant Foods Hum Nutr 2010; 65: 374-378.
12. Lin CC, Yin MC, Hsu CC, Lin MP. Effect of five cysteine-containing compounds on three lipogenic enzymes in Balb/cA mice consuming a high saturated fat diet. Lipids 2004; 39: 843-848.
13. Mong MC, Yin MC. Nuclear factor icB-dependent anti-inflammatory effects of s-allyl cysteine and s-propyl cysteine in kidney of diabetic mice. J Agric Food Chem 2012; 60: 3158-3165.
14. Hsu CC, Yen HF, Yin MC, Tsai CM, Hsieh CH. Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J Nutr 2004; 134: 3245-3249.
15. Saravanan G, Ponmurugan P. Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats. Chem Biol Interact 2011; 189: 100-106.
16. Li S, Ogawa W, Emi A, et al. Role of S6K1 in regulation of SREBPlc expression in the liver. Biochem Biophys Res Commun 2011; 412: 197-202.
17. Holness MJ, Bulmer K, Smith ND, Sugden MC. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone. Biochem J 2003; 369: 687-695. (Pubitemid 36246254)
18. Holness MJ, Bulmer K, Gibbons GF, Sugden MC. Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator- activated receptor a (PPARa). Biochem J 2002; 366: 839-846.
19. Duan SZ, Usher MG, Mortensen RM. PPARs: The vasculature, inflammation and hypertension. Curr Opin Nephrol Hypertens 2009; 18: 128-133.
20. Romics L Jr, Kodys K, Dolganiuc A, et al. Diverse regulation of NF-kB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. Hepatology 2004; 40: 376-385. (Pubitemid 39062855)
21. Sugden MC, Bulmer K, Gibbons GF, Knight BL, Holness MJ. Peroxisome-proliferator-activated receptor-a (PPARa) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochem J 2002; 364: 361-368. (Pubitemid 34620795)
22. Holness MJ, Kraus A, Harris RA, Sugden MC. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes 2000; 49: 775-781. (Pubitemid 30339993)
23. Wu P, Blair PV, Sato J, Jaskiewicz J, Popov KM, Harris RA. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch Biochem Biophys 2000; 381: 1-7.
24. Wu P, Sato J, Zhao Y, Jaskiewicz J, Popov KM, Harris RA. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J1998; 329: 197-201. (Pubitemid 28022309)
25. Horiuchi M, Kobayashi K, Masuda M, Terazono H, Saheki T. Pyruvate dehydrogenase kinase 4 mRNA is increased in the hypertrophied ventricles of camitine-deficient juvenile visceral steatosis (JVS) mice. Biofactors 1999; 10: 301-309. (Pubitemid 29533845)
26. Pilegaard H, Neufer PD. Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc 2004; 63:221-226. (Pubitemid 38787469)
27. Chen J, Sun M, Liang B, Xu A, Zhang S, Wu D. Cloning and expression of PDK4, FOXOIA and DYRK1A from the hibernating greater horseshoe bat (Rhinolophus ferrumequinum). Comp Biochem Physiol B Biochem Mol Biol 2007; 146: 166-171. (Pubitemid 46201915)
28. Kim DH, Zhang T, Ringquist S, Dong HH. Targeting FoxOl for Hypertriglyceridemia. Curr Drug Targets 2011; 12: 1245-1255.